 effect atenolol diltiazem heart period variabl normal person sever time frequenc domain measur heart period variabl week myocardi infarct reduc standard deviat normal RR interv period sdnn increas mortal predict accuraci heart period variabl drug patient myocardi infarct random period placebo-control crossov latin squar design effect atenolol time frequenc measur heart period variabl continu electrocardiograph record treatment atenolol diltiazem placebo normal volunt atenolol treatment averag normal RR NN interv measur tonic vagal activ atenolol treatment percent success normal RR interv ms root mean squar success differ normal RR interv high frequenc power heart period power spectrum low frequenc power variabl indic tonic vagal activ diltiazem signific effect averag NN interv measur heart period variabl decreas mortal rate myocardi infarct beta-adrenerg blocker calcium channel blocker therapi part increas vagal tone beta-block